Brandeis University, Institute for Behavioral Health, Heller School for Social Policy and Management, Waltham, MA 02454, USA.
J Subst Abuse Treat. 2011 Jan;40(1):35-43. doi: 10.1016/j.jsat.2010.08.005. Epub 2010 Oct 8.
Performance measures have the potential to drive high-quality health care. However, technical and policy challenges exist in developing and implementing measures to assess substance use disorder (SUD) pharmacotherapy. Of critical importance in advancing performance measures for use of SUD pharmacotherapy is the recognition that different measurement approaches may be needed in the public and private sectors and will be determined by the availability of different data collection and monitoring systems. In 2009, the Washington Circle convened a panel of nationally recognized insurers, purchasers, providers, policy makers, and researchers to address this topic. The charge of the panel was to identify opportunities and challenges in advancing use of SUD pharmacotherapy performance measures across a range of systems. This article summarizes those findings by identifying a number of critical themes related to advancing SUD pharmacotherapy performance measures, highlighting examples from the field, and recommending actions for policy makers.
绩效措施有可能推动高质量的医疗保健。然而，在制定和实施评估物质使用障碍（SUD）药物治疗的措施方面存在技术和政策挑战。在推进 SUD 药物治疗使用的绩效措施方面，至关重要的是认识到在公共和私营部门可能需要不同的测量方法，并且将取决于不同的数据收集和监测系统的可用性。2009 年，华盛顿圈召集了一批全国知名的保险公司、购买者、提供者、政策制定者和研究人员来解决这个问题。该小组的任务是确定在一系列系统中推进 SUD 药物治疗绩效措施的机会和挑战。本文通过确定与推进 SUD 药物治疗绩效措施相关的一些关键主题，突出该领域的例子，并为政策制定者推荐行动，总结了这些发现。
